EGFR Gene
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What the EGFR Gene Means in Everyday Language
The EGFR gene is a part of your body's instructions for making a protein called the epidermal growth factor receptor. This protein sits on the surface of some cells and helps control how they grow and survive. When the EGFR gene works normally, it helps keep cell growth balanced. But sometimes, changes called mutations happen in the EGFR gene. These changes can cause the protein to be made in larger amounts or become overactive, which may lead to cells growing too quickly and forming cancer.
Why the EGFR Gene Matters in Cancer Care
Mutations in the EGFR gene are found in some types of cancer, especially certain non-small cell lung cancers. Knowing whether a tumor has these changes can help doctors choose treatments that specifically target the EGFR protein. These targeted therapies aim to block the signals that tell cancer cells to grow and divide, potentially slowing or stopping the cancer. This approach is part of personalized cancer care, where treatments are tailored to the unique features of a patient’s tumor.
What Patients Might See or Hear About the EGFR Gene
You might hear your care team mention the EGFR gene when discussing test results or treatment options. The gene may also be called the epidermal growth factor receptor gene, ERBB1 gene, or HER1 gene. These different names refer to the same gene, so it’s helpful to ask your care team if you’re unsure. If your tumor has changes in the EGFR gene, your doctor might talk about targeted drugs like erlotinib, afatinib, or amivantamab, which work by blocking the EGFR protein.
How Doctors Use EGFR Gene Information
Doctors often test tumor tissue for EGFR gene mutations when lung cancer is diagnosed or if the cancer has returned or worsened after treatment. Finding these mutations can help decide if targeted therapies are a good option. These drugs are usually considered when standard chemotherapy is less effective or not suitable. The choice to use EGFR-targeted treatments depends on many factors, including the specific mutations found, the type and stage of cancer, and the patient’s overall health.
What the EGFR Gene Does Not Automatically Mean
Seeing the term EGFR gene in your medical records or hearing it mentioned does not mean you have a specific diagnosis or that a particular treatment is guaranteed to work. It is one part of a larger picture your care team uses to plan your care. Not all cancers have EGFR mutations, and not all patients with these mutations respond the same way to targeted treatments. It’s important to discuss what your test results mean for you personally.
Common Questions to Ask Your Care Team
If the EGFR gene comes up in your care, you might ask: What does this gene change mean for my cancer? Are there targeted treatments available for my situation? What are the possible benefits and side effects of these treatments? How will we monitor if the treatment is working? Are there clinical trials or other options I should consider? These questions can help you understand your care and feel more involved in decisions.
Understanding EGFR Gene Information in Context
Because the EGFR gene has several names and is linked to different treatments, it’s important to look at the full context in your medical records or discussions. Don’t assume the gene name alone tells the whole story. Always ask your care team how this information applies to your specific diagnosis and treatment plan.
Safety and Next Steps
This information is meant to help you understand the EGFR gene and its role in cancer care. It does not replace personalized medical advice. If you see the term EGFR gene in your records or hear it mentioned, the best next step is to ask your care team what it means for you. They can explain how it fits into your diagnosis, treatment options, and what to expect moving forward.
Sources
Public source information used for this glossary entry includes: